Phospholipase A(2) inhibitor–loaded micellar nanoparticles attenuate inflammation and mitigate osteoarthritis progression

Treating osteoarthritis (OA) remains a major clinical challenge. Despite recent advances in drug discovery and development, no disease-modifying drug for knee OA has emerged with any notable clinical success, in part, due to the lack of valid and responsive therapeutic targets and poor drug delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yulong, Yan, Lesan, Luo, Lijun, Gui, Tao, Jang, Biang, Amirshaghaghi, Ahmad, You, Tianyan, Tsourkas, Andrew, Qin, Ling, Cheng, Zhiliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026133/
https://www.ncbi.nlm.nih.gov/pubmed/33827816
http://dx.doi.org/10.1126/sciadv.abe6374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026133/
https://www.ncbi.nlm.nih.gov/pubmed/33827816
http://dx.doi.org/10.1126/sciadv.abe6374

Ejemplares similares